Business description
bioMérieux S.A. is one of the world leaders in the field of in vitro diagnostics for over 50 years. bioMérieux is present in more than 160 countries through 42 subsidiaries and a large network of distributors. bioMérieux provides diagnostic solutions (reagents, instruments, software and services) which determine the source of disease and contamination to improve patient health and ensure product safety. In clinical applications, the Company offers a wide range of solutions for managing infectious diseases, cardiovascular diseases and targeted cancers. For the agri-food, cosmetics and pharmaceutical industries, bioMérieux provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing.
Management board & Supervisory board
| CEO |
| Pierre Boulud |
| Management board |
| Guillaume Bouhours, Pierre Charbonnier, Audrey Dauvet, François Lacoste, Valérie Leyldé, Mark Miller, Yasha Mitrotti, Jennifer Zinn |
| Supervisory board |
| Alexandre Mérieux, Alain Mérieux, Jean-Luc Bélingard, Marie-Hélène Habert-Dassault, Philippe Archinard, Harold Boël, Fanny Letier, Marie-Paule Kieny, Sylvain Orenga |
Company data
| Name: |
bioMerieux S.A. |
| Address: |
Chemin de l'Orme,F-69280 Marcy l'Etoile |
| Phone: |
+33-4-7887-2000 |
| Fax: |
+33-4-7887-2090 |
| E-mail: |
-
|
| Internet: |
www.biomerieux.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12-31 |
| Free Float: |
33.97% |
| IPO date: |
- |
